Estrella Immunopharma (ESLA) Earnings Date & Reports
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
ESLA is expected to report earnings to rise 280.00% to -18 cents per share on December 02
Q3'26
Est.
$-0.19
Q2'26
Beat
by $0.12
Q1'26
Beat
by $0.13
Q2'25
Missed
by $0.04
Q1'25
Beat
by $0.05
The last earnings report on September 02 showed earnings per share of -5 cents, beating the estimate of -17 cents. With 7.09K shares outstanding, the current market capitalization sits at 29.35M.